Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds
- 19 June 2007
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- No. 29,p. 3131-3139
Abstract
The production of bone substitute biomimetic materials which could also act as antitumoral drug release agents is of enormous interest. We report in this paper the synthesis and characterization of a novel platinum dinuclear complex containing a geminal bisphosphonate and its embodiment into xerogels prepared by the sol–gel method. Our goal was to obtain a hybrid inorganic matrix that could release a platinum species active against bone tumors or metastases, upon local implant. Two silica xerogels were considered: one was composed of pure silica, while the other contained also some calcium as potential release-modulating agent thanks to its high affinity for bisphophonates. The platinum-complex loading capacity of the inorganic matrices, the release kinetics in buffer simulating physiological conditions, and the stability upon storage were investigated as a function of Pt-complex concentration and calcium addition. We found that the presence of calcium in the composites deeply influences not only the stability of the formulations but also the nature of the platinum complex liberated in solution.Keywords
This publication has 39 references indexed in Scilit:
- Coordination abilities of piperyd-1-yl-methane-1,1-diphosphonic acids towards zinc(II), magnesium(II) and calcium(II): Potentiometric and NMR studiesJournal of Inorganic Biochemistry, 2006
- The Effect of PEG Concentration on the Release Rate of Cisplatin from PEG-Modified Silica XerogelsDrug Delivery, 2006
- Platinum Complexes with the Novel Ligand Diethyl [(Methylsulfinyl)‐methyl]phosphonate (SMP): Solid‐State Characterization of Potassium Trichloro(SMP)platinum( II ) which, in Solution, Gives Dichloro(SMP)‐platinum( II ) and Potassium ChlorideEuropean Journal of Inorganic Chemistry, 2005
- Synthesis and Characterization of Platinum(II) Complexes of Diethyl [(Methylsulfinyl)methyl]phosphonate: Potential Drugs against Bone TumorsEuropean Journal of Inorganic Chemistry, 2004
- In Vitro Release of Cisplatin from Sol-Gel Processed Porous Silica XerogelsDrug Delivery, 2004
- A Quantitative Structure−Activity Relationship and Pharmacophore Modeling Investigation of Aryl-X and Heterocyclic Bisphosphonates as Bone Resorption AgentsJournal of Medicinal Chemistry, 2003
- Cisplatin-linked phosphonates in the treatment of the transplantable osteosarcoma in vitro and in vivoCancer Treatment Reviews, 1990
- NMR spectra of iminobis(methylenephosphonic acid), HN(CH2PO3H2)2, and related ligands and of their complexes with platinum(II)Inorganic Chemistry, 1986
- Multinuclear NMR study of reactions of methylphosphonic acid, CH3PO3H2, and (aminoalkyl)phosphonic acids, NH2(CH2)nPO3H2 (n = 1-3), with the cis-diamminediaquaplatinum(II) cation and cis-diamminedihydroxoplatinum(II)Inorganic Chemistry, 1986
- N.M.R. study of acid-base equilibria of aminoalkylphosphonic acids, +NH3(CH2)nPO3H- (n = 1,2,3): Evidence for cyclization in solutionAustralian Journal of Chemistry, 1984